Childrens Mylicon Tummy Relief For Kids Tablet, Chewable
NDC Package 62372-400-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Childrens Mylicon Tummy Relief For Kids (antacid and antigas) tablets is •follow directions based on age/weight below•repeat as needed•do not use the maximum dosage for more than two weeks except under the advice and supervision of a doctor WeightAgeDosageunder 24 lbsunder 2 yrsask a doctor24-47 lbs2-5 yrs 1 tablet, Not more than 3 tablets in 24 hours48-95 lbs6-11 yrs2 tablets, Not more than 6 tablets in 24 hours. This formulation utilizes a tablet, chewable delivery system. Marketed by Infirst Healthcare Inc., this product is identified by NDC 62372-400 and is authorized under FDA application M002.

Identification & Billing

NDC Package Code
62372-400-24
Package Description
24 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC
Product Code
62372-400
11-Digit Billing Format
62372040024
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
24 EA
RxNorm Crosswalk
  • RxCUI: 1999195 - calcium carbonate 400 MG / simethicone 40 MG Chewable Tablet
  • RxCUI: 1999202 - MYLICON Children's 400 MG/ 40 MG Chewable Tablet
  • RxCUI: 1999202 - calcium carbonate 400 MG / simethicone 40 MG Chewable Tablet [Mylicon Children's]
  • RxCUI: 1999202 - Mylicon Children's (calcium Carbonate 400 MG / simethicone 40 MG) Chewable Tablet

Clinical Specifications

Proprietary Name
Childrens Mylicon Tummy Relief For Kids
Non-Proprietary Name
Antacid And Antigas
Substance Name
Calcium Carbonate; Dimethicone
Dosage Form
Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
•follow directions based on age/weight below•repeat as needed•do not use the maximum dosage for more than two weeks except under the advice and supervision of a doctor WeightAgeDosageunder 24 lbsunder 2 yrsask a doctor24-47 lbs2-5 yrs 1 tablet, Not more than 3 tablets in 24 hours48-95 lbs6-11 yrs2 tablets, Not more than 6 tablets in 24 hours

Regulatory & Marketing

Labeler Name
Infirst Healthcare Inc.
Product Type
Human Otc Drug
FDA Application #
M002
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-09-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (62372-400). Click a package code to view its specific billing and regulatory data.

62372-400-02
2 TABLET, CHEWABLE in 1 POUCH

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62372-400-24 identifies a specific commercial package of 24 tablet, chewable in 1 bottle, plastic of Childrens Mylicon Tummy Relief For Kids, a human over the counter drug labeled by Infirst Healthcare Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 24 billable units per package. This tablet, chewable is formulated for oral use and contains calcium carbonate; dimethicone as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Infirst Healthcare Inc. on February 09, 2018. The current certification is valid through December 31, 2026.

How is this Infirst Healthcare Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62372040024. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 24 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62372-400-24
11-Digit CMS (5-4-2)
62372-0400-24

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.